Summary of all TEAEs that occurred in ≥20% of patients
| Preferred term . | Grade 1-2 . | Grade ≥3 . | All grades . |
|---|---|---|---|
| Diarrhea | 44 (49) | 1 (1) | 45 (50) |
| Fatigue | 33 (37) | 9 (10) | 42 (47) |
| Nausea | 40 (44) | 1 (1) | 41 (46) |
| Febrile neutropenia | 0 (0) | 38 (42) | 38 (42) |
| Decreased appetite | 31 (34) | 2 (2) | 33 (37) |
| Vomiting | 32 (36) | 1 (1) | 33 (37) |
| Cough | 26 (29) | 0 (0) | 26 (29) |
| Anemia | 9 (10) | 15 (17) | 24 (27) |
| Hypokalemia | 16 (18) | 6 (7) | 22 (24) |
| Aspartate aminotransferase increased | 14 (16) | 5 (6) | 19 (21) |
| Dyspnea | 15 (17) | 3 (3) | 18 (20) |
| Preferred term . | Grade 1-2 . | Grade ≥3 . | All grades . |
|---|---|---|---|
| Diarrhea | 44 (49) | 1 (1) | 45 (50) |
| Fatigue | 33 (37) | 9 (10) | 42 (47) |
| Nausea | 40 (44) | 1 (1) | 41 (46) |
| Febrile neutropenia | 0 (0) | 38 (42) | 38 (42) |
| Decreased appetite | 31 (34) | 2 (2) | 33 (37) |
| Vomiting | 32 (36) | 1 (1) | 33 (37) |
| Cough | 26 (29) | 0 (0) | 26 (29) |
| Anemia | 9 (10) | 15 (17) | 24 (27) |
| Hypokalemia | 16 (18) | 6 (7) | 22 (24) |
| Aspartate aminotransferase increased | 14 (16) | 5 (6) | 19 (21) |
| Dyspnea | 15 (17) | 3 (3) | 18 (20) |
Values are n (%). TEAE defined as AE with start date on or after C1D1.